1. Kuehn BM. Questionable Antipsychotic Prescribing Remains Common, Despite Serious Risks. JAMA. 2010;303(16):1582–4.
2. US Food and Drug Administration. Public Health Advisory: Deaths With Antipsychotics in Elderly Patients With Behavioral Disturbances. Silver Spring, MD: US Food and Drug Administration; 2005. Available at: www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ ucm053171.htm . Accessed May 15 2014.
3. US Food and Drug Administration. FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs [news release]. Silver Spring, MD: US Food and Drug Administration; 2008. Cited June 24, 2008. Available at: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ 2008/ucm116912.htm.
4. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf. 2011;20(2):177–84.
5. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on memory in aging. Am J Psychiatr. 2000;157:708–14.